PatenSeePatenSee
PatenSee

PatenSee

Machine learning tool for early detection of vascular access stenosis in hemodialysis patients.

2019Active5

About

PatenSee is a clinical-stage medical device company developing a contactless, optical imaging system for rapid vascular access monitoring in dialysis patients. Their technology, combined with AI, digitizes and standardizes the physical examination of vascular access sites to enable early prediction of stenosis and other complications. This system serves as a clinical support tool for dialysis clinics, aiming to protect the patient's lifeline and improve the quality of care.

Technology stack

detected 2026-06-17
Est. monthly stack spend~$90/mo
CDN
Cloudflare
EmailMicrosoft 365
Stack
jQueryBootstrapWordPress
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does PatenSee do?

PatenSee is a clinical-stage medical device company developing a contactless, optical imaging system for rapid vascular access monitoring in dialysis patients. Their technology, combined with AI, digitizes and standardizes the physical examination of vascular access sites to enable early prediction of stenosis and other complications. This system serves as a clinical support tool for dialysis clinics, aiming to protect the patient's lifeline and improve the quality of care.

When was PatenSee founded?

PatenSee was founded in 2019.

What industry does PatenSee operate in?

PatenSee operates in Healthcare, Disease, Detection, Prevention, Clinical, Workflow.

How many employees does PatenSee have?

PatenSee has approximately 5 people on record.